Humana Debt-to-Equity Ratio Growth & History (HUM)
Humana's debt-to-equity ratio was 0.73 for fiscal 2025.
View full Humana company overviewHumana annual debt-to-equity ratio history
| Fiscal year | Period ended | Debt-to-equity ratio | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | 0.73 | −0.02 | −2.19% |
| 2024 | 2024-12-31 | 0.75 | −0.01 | −0.74% |
| 2023 | 2023-12-31 | 0.75 | −0.01 | −1.72% |
| 2022 | 2022-12-31 | 0.77 | −0.06 | −6.82% |
| 2021 | 2021-12-31 | 0.82 | 0.30 | +58.04% |
| 2020 | 2020-12-31 | 0.52 | 0.01 | +2.45% |
| 2019 | 2019-12-31 | 0.51 | −0.09 | −14.96% |
| 2018 | 2018-12-31 | 0.60 | 0.10 | +19.48% |
| 2017 | 2017-12-31 | 0.50 | 0.12 | +30.53% |
| 2016 | 2016-12-31 | 0.38 | −0.01 | −3.20% |
| 2015 | 2015-12-31 | 0.40 | −0.00 | −0.23% |
| 2014 | 2014-12-31 | 0.40 | 0.12 | +42.08% |
| 2013 | 2013-12-31 | 0.28 | −0.02 | −5.43% |
| 2012 | 2012-12-31 | 0.30 | 0.09 | +43.44% |
| 2011 | 2011-12-31 | 0.21 | −0.04 | −14.64% |
| 2010 | 2010-12-31 | 0.24 | −0.05 | −17.04% |
| 2009 | 2009-12-31 | 0.29 | −0.14 | −33.15% |
| 2008 | 2008-12-31 | 0.43 | — | — |
Humana quarterly debt-to-equity ratio
| Fiscal quarter | Period ended | Debt-to-equity ratio | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | 0.74 | 0.05 | +7.43% |
| Q1 2026 | 2026-03-31 | 0.75 | 0.00 | +0.47% |
| Q4 2025 | 2025-12-31 | 0.73 | −0.02 | −2.19% |
| Q3 2025 | 2025-09-30 | 0.68 | −0.06 | −8.19% |
| Q2 2025 | 2025-06-30 | 0.69 | −0.08 | −10.76% |
| Q1 2025 | 2025-03-31 | 0.75 | −0.07 | −8.49% |
| Q4 2024 | 2024-12-31 | 0.75 | −0.01 | −0.74% |
| Q3 2024 | 2024-09-30 | 0.74 | 0.05 | +7.14% |
| Q2 2024 | 2024-06-30 | 0.77 | 0.08 | +10.87% |
| Q1 2024 | 2024-03-31 | 0.82 | 0.12 | +16.95% |
| Q4 2023 | 2023-12-31 | 0.75 | −0.01 | −1.72% |
| Q3 2023 | 2023-09-30 | 0.69 | 0.04 | +6.55% |
| Q2 2023 | 2023-06-30 | 0.70 | −0.13 | −15.67% |
| Q1 2023 | 2023-03-31 | 0.70 | −0.15 | −17.19% |
| Q4 2022 | 2022-12-31 | 0.77 | −0.06 | −6.82% |
| Q3 2022 | 2022-09-30 | 0.65 | −0.10 | −13.76% |
| Q2 2022 | 2022-06-30 | 0.83 | 0.34 | +71.21% |
| Q1 2022 | 2022-03-31 | 0.85 | 0.33 | +65.16% |
| Q4 2021 | 2021-12-31 | 0.82 | 0.30 | +58.04% |
| Q3 2021 | 2021-09-30 | 0.75 | 0.26 | +52.56% |
| Q2 2021 | 2021-06-30 | 0.48 | −0.06 | −10.49% |
| Q1 2021 | 2021-03-31 | 0.51 | −0.13 | −20.47% |
| Q4 2020 | 2020-12-31 | 0.52 | 0.01 | +2.45% |
| Q3 2020 | 2020-09-30 | 0.49 | −0.07 | −12.01% |
| Q2 2020 | 2020-06-30 | 0.54 | 0.02 | +3.85% |
| Q1 2020 | 2020-03-31 | 0.64 | 0.04 | +6.67% |
| Q4 2019 | 2019-12-31 | 0.51 | −0.09 | −14.96% |
| Q3 2019 | 2019-09-30 | 0.56 | 0.07 | +14.90% |
| Q2 2019 | 2019-06-30 | 0.52 | 0.01 | +2.64% |
| Q1 2019 | 2019-03-31 | 0.60 | 0.09 | +17.70% |
| Q4 2018 | 2018-12-31 | 0.60 | 0.10 | +19.48% |
| Q3 2018 · Sep 30 | 2018-09-30 | 0.49 | 0.05 | +11.03% |
| Q2 2018 | 2018-06-30 | 0.51 | 0.05 | +11.38% |
| Q1 2018 | 2018-03-31 | 0.51 | −0.00 | −0.03% |
| Q4 2017 | 2017-12-31 | 0.50 | 0.12 | +30.53% |
| Q3 2017 | 2017-09-30 | 0.44 | 0.08 | +21.27% |
| Q2 2017 | 2017-06-30 | 0.45 | 0.08 | +20.79% |
| Q1 2017 | 2017-03-31 | 0.51 | 0.12 | +31.92% |
| Q4 2016 | 2016-12-31 | 0.38 | −0.01 | −3.20% |
| Q3 2016 | 2016-09-30 | 0.36 | −0.01 | −2.06% |
| Q2 2016 | 2016-06-30 | 0.38 | −0.03 | −7.95% |
| Q1 2016 | 2016-03-31 | 0.39 | 0.01 | +2.14% |
| Q4 2015 | 2015-12-31 | 0.40 | −0.00 | −0.23% |
| Q3 2015 | 2015-09-30 | 0.37 | −0.06 | −13.59% |
| Q2 2015 | 2015-06-30 | 0.41 | 0.15 | +57.57% |
| Q1 2015 | 2015-03-31 | 0.38 | 0.11 | +42.52% |
| Q4 2014 | 2014-12-31 | 0.40 | 0.12 | +42.08% |
| Q3 2014 | 2014-09-30 | 0.43 | 0.16 | +58.11% |
| Q2 2014 | 2014-06-30 | 0.26 | −0.02 | −7.04% |
| Q1 2014 | 2014-03-31 | 0.27 | −0.02 | −6.13% |
| Q4 2013 | 2013-12-31 | 0.28 | −0.02 | −5.43% |
| Q3 2013 | 2013-09-30 | 0.27 | 0.09 | +45.73% |
| Q2 2013 | 2013-06-30 | 0.28 | 0.09 | +45.88% |
| Q1 2013 | 2013-03-31 | 0.28 | 0.09 | +44.56% |
| Q4 2012 | 2012-12-31 | 0.30 | 0.09 | +43.44% |
| Q3 2012 | 2012-09-30 | 0.19 | −0.03 | −12.06% |
| Q2 2012 | 2012-06-30 | 0.19 | −0.03 | −12.75% |
| Q1 2012 | 2012-03-31 | 0.20 | −0.03 | −14.62% |
| Q4 2011 | 2011-12-31 | 0.21 | −0.04 | −14.64% |
| Q3 2011 | 2011-09-30 | 0.21 | −0.03 | −12.21% |
| Q2 2011 | 2011-06-30 | 0.22 | −0.04 | −15.09% |
| Q1 2011 | 2011-03-31 | 0.23 | −0.04 | −16.27% |
| Q4 2010 | 2010-12-31 | 0.24 | −0.05 | −17.04% |
| Q3 2010 | 2010-09-30 | 0.24 | −0.06 | −20.48% |
| Q2 2010 | 2010-06-30 | 0.26 | −0.07 | −22.35% |
| Q1 2010 | 2010-03-31 | 0.28 | — | — |
| Q4 2009 | 2009-12-31 | 0.29 | −0.14 | −33.15% |
| Q3 2009 | 2009-09-30 | 0.30 | — | — |
| Q2 2009 | 2009-06-30 | 0.33 | — | — |
| Q4 2008 | 2008-12-31 | 0.43 | — | — |
Humana debt-to-equity ratio trends
Over the last five fiscal years, Humana's debt-to-equity ratio increased from 0.52 to 0.73, a change of 0.21. The latest reported quarter, Q2 2026, shows 0.74.
What the debt-to-equity ratio means
The debt-to-equity ratio compares interest-bearing debt with shareholders’ equity. It helps show how much debt financing a company uses relative to its accounting equity, but useful comparison levels vary by industry.
How debt-to-equity is calculated
TickerStat calculates debt-to-equity as total interest-bearing debt divided by SEC-reported shareholders’ equity for the same balance-sheet date. Total liabilities are not treated as debt, and periods with non-positive equity are omitted. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Humana source filings ↗